NCT02272790 2023-10-03Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerAstraZenecaPhase 2 Completed95 enrolled 61 charts
NCT00550771 2017-06-07Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)Merck Sharp & Dohme LLCPhase 2 Completed181 enrolled 9 charts